This is a preview of subscription content, log in via an institution to check access.
References
Holmberg, K., Meyer, R. D. Fungal infections in patients with AIDS and AIDS-related complex. Scan. J. Infect. Dis. 18 (1986) 179–192.
Centers for Disease Control Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36 (1987) Suppl. 1S pp. 3–15.
Lake-Bakaar, G., Tom, W., Lake-Bakaar, D., Gupta, N., Beidas, S., Elsakr, M., Straus, E. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 109 (1988) 471–473.
Saag, M. S., Dismukes, W. E. Azole antifungal agents: Emphasis on new triazoles. Antimicrob. Agents Chemother. 32 (1988) 1–8.
Dismukes, W. E. Azoles antifungal drugs: Old and new (Editorial). Ann. Intern. Med. 109 (1988) 177–179.
Selik, R. M., Starcher, T., Curran, J. W. Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1 (1987) 175–182.
Clumeck, N., De Wit, S. AIDS in Africa. In:Sande, M. A., Volberding, P. A. (eds.): The medical management of AIDS. W. B. Saunders Company, Philadelphia 1988, pp. 331–349.
Stern, J. J., Hartman, B. J., Sharkey, P., Rowland, V., Squires, K. E., Murray, H. W., Graybill, J. R. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: Experience with 22 patients. Am. J. Med. 85 (1988) 477–480.
Byrne, W. R., Wajszczuk, C. P. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): Successful treatment with fluconazole after failure of amphotericin B. Ann. Intern. Med. 108 (1988) 384–385.
Sugar, A. M., Saunders, C. Oral fluconazole suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85 (1988) 481–489.
Odds, F. C., Webster, C. E. Effects of azole antifungalsin vitro on host/parasite interactions relevant to candida infections. J. Antimicrob. Chemother. 22 (1988) 473–481.
Dupont, B., Drouhet, E.: Fluconazole in the management of oropharyngeal candidiasis in a predominantly HIV antibody-positive group of patients. In:Fromtling, R. A. (ed.): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers 1987.
Meunier, F., Gerain, J., Snoeck, R., Libotte, F., Lambert, C., Ceuppens, A. M.: Fluconazole therapy of oropharyngeal candidiasis in cancer patients. In:Fromtling, R. A. (ed.): Recent trends in the discovery, development and evaluation of antifungal agents. J. R. Prous Science Publishers 1987.
De Wit, S., Weerts, D., Goossens, H., Clumeck, N. Comparison of Fluconazole and Ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1 (1989) 746–747.
Pape, J. W., Liautaud, B., Thomas, F., Mathurin, J. R., St. Amand, M. M. A., Boncy, M., Pean, V., Pamphile, M., Laroche, C., Dehovitz, J., Johnson, W. D. The acquired immunodeficiency syndrome in Haiti. Ann. Intern. Med. 103 (1985) 674–678.
Deschamps, M. M. H., Pape, J. W., Verdier, R. I., De Hovitz, J., Thomas, F., Johnson, W. D. Treatment of candida esophagitis in AIDS patients. Am. J. Gastroenterol. 83 (1988) 20–21.
Van't Wout, J. W., Mattie, H., van Furth, R. A prospective study of the efficacy of Fluconazole (UK-49, 858) against deep-seated fungal infections. J. of Antimicrob. Chemother. 21 (1988) 665–672.
De Wit, S., Weerts, D., Urbain, D., Clumeck, N.: Efficacy of oral Fluconazole in the treatment of oesophageal candidiasis associated with AIDS. Submitted for publication.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Wit, S., Clumeck, N. Fluconazole in the treatment of fungal infections associated with AIDS. Infection 17, 121–123 (1989). https://doi.org/10.1007/BF01644009
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644009